Novo Nordisk A/S (NYSE:NVO)

64.14
Delayed Data
As of Feb 19
 +0.05 / +0.08%
Today’s Change
46.47
Today|||52-Week Range
64.82
+10.82%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 66.84, with a high estimate of 73.61 and a low estimate of 32.87. The median estimate represents a +4.21% increase from the last price of 64.14.

Analyst Recommendations

The current consensus among 28 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.68
Sales
$4.5B
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 24.93%
 
 
 
 
 
 
Growthannually 12.90%
 
 
 
 
 
 

Sales

Growthquarterly -4.78%
 
 
 
 
 
 
Growthannually 6.29%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.